Cargando…
ROCK Inhibition May Stop Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and is strongly associated with cardiovascular mortality. Given the pandemic of obesity and diabetes, the elucidation of the molecular underpinnings of DKD and establishment of effective therapy are urgently required. Stud...
Autores principales: | Matoba, Keiichiro, Takeda, Yusuke, Nagai, Yosuke, Kanazawa, Yasushi, Kawanami, Daiji, Yokota, Tamotsu, Utsunomiya, Kazunori, Nishimura, Rimei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590381/ https://www.ncbi.nlm.nih.gov/pubmed/33150249 http://dx.doi.org/10.31662/jmaj.2020-0014 |
Ejemplares similares
-
The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020) -
ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells
por: Takeda, Yusuke, et al.
Publicado: (2019) -
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2019) -
ROCK2-induced metabolic rewiring in diabetic podocytopathy
por: Matoba, Keiichiro, et al.
Publicado: (2022) -
Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes
por: Matoba, Keiichiro, et al.
Publicado: (2021)